To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1370350
Sale price1.202,33 €
|
Lorazepam Related Compound D (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic acid) |
R084F0 | 54643-79-7 | 1.202,33 € | |
|
USP-1370360
Sale price1.029,40 €
|
Lorazepam Related Compound E (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol) |
R142T0 | 773871-49-1 | 1.029,40 € | |
|
USP-1370473
Sale price1.028,23 €
|
Losartan Related Compound A (20 mg) (2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde) |
F0M332 | 83857-96-9 | 1.028,23 € | |
|
USP-1370484
Sale price1.018,88 €
|
Losartan Related Compound B (20 mg) (2-Butyl-4-chloro-(1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methyl acetate) |
F01140 | 1006062-27-6 | 1.018,88 € | |
|
USP-1370495
Sale price999,02 €
|
Losartan Related Compound C (20 mg) (2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carbaldehyde) |
F01150 | 114798-36-6 | 999,02 € | |
|
USP-1370509
Sale price1.153,25 €
|
Losartan Related Compound D (20 mg) (5-[4'-({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1H-tetrazol-1-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazole, potassium salt) |
R211F0 | 212316-86-4 | 1.153,25 € | |
|
USP-1370510
Sale price1.050,43 €
|
Losartan Related Compound E (20 mg) (4'-[({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-2H-tetrazol-2-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazole, potassium salt) |
R211G0 | 212316-88-6 | 1.050,43 € | |
|
USP-1370611
Sale price1.062,11 €
|
Lovastatin Related Compound A (20 mg) (4,4a-Dihydrolovastatin) |
R052X0 | N/A | 1.062,11 € | |
|
USP-1370655
Sale price508,27 €
|
Lovastatin Impurity Identification Mixture (30 mg) |
F002Q0 | N/A | 508,27 € | |
|
USP-1370688
Sale price266,40 €
|
Low-substituted carboxymethyl cellulose sodium (100 mg) |
F08970 | 9004-32-4 | 266,40 € | |
|
USP-1370699
Sale price916,06 €
|
Loxapine N-oxide (25 mg) (4-(2-Chlorodibenzo[b,f][1,4]oxazepin-11-yl)-1-methylpiperazine 1-oxide) |
F15240 | 25967-34-4 | 916,06 € | |
|
USP-1370713
Sale price999,02 €
|
Loxapine Related Compound A (20 mg) (3-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine) |
R21810 | 3454-96-4 | 999,02 € | |
|
USP-1370724
Sale price1.080,81 €
|
Lufenuron Related Compound B (15 mg) (N-[(2,5-Dichloro-4-hydroxyphenyl)carbamoyl]-2,6-difluorobenzamide) |
R185A0 | 2767988-84-9 | 1.080,81 € | |
|
USP-1370735
Sale price1.080,81 €
|
Lufenuron Related Compound C (15 mg) (N-[3-Chloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylcarbamoyl]-2,6-difluorobenzamide) |
R18650 | N/A | 1.080,81 € | |
|
USP-1370757
Sale price1.163,77 €
|
Lumefantrine Related Compound A (25 mg) ((RS, Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol hydrochloride) |
R185X0 | NA | 1.163,77 € | |
|
USP-1370780
Sale price1.080,81 €
|
Lufenuron Related Compound G (15 mg) (2,5-Dichloro-4-[3-(2,6-difluorobenzoyl)ureido]phenyl phenyl carbonate) |
N/A | 1.080,81 € | ||
|
USP-1370837
Sale price472,05 €
|
Luteolin 7-O-Glucoside (30 mg) (2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside) |
R121A0 | 5373-11-5 | 472,05 € |
